Skip to main content

Alimera Sciences Inc

ALIMDelisted Sep 16, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001267602

Alimera Sciences Inc was delisted on Sep 16, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 52 institutions reported holding it in 13F filings for Q2 2024, worth $257.9M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Alimera Sciences Inc changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of ALIM: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders27121−5
Shares1.96M38.2K1.77M−153.7K (−8.0%)
Value$8.29M$162.0K$9.09M+$962.5K (+11.8%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (2)

Institutions that held Alimera Sciences Inc at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ALIM in Q4 2021
InstitutionSharesValue% of portfolio
Millennium Management LLC12,716$65.0K0.00%
Bank of America Corp6$00.00%

Sold out (7)

Institutions that held Alimera Sciences Inc at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of ALIM in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Diametric Capital, LP24,473$103.0K
Ensign Peak Advisors, Inc19,151$81.0K
Common Fund for Nonprofit Organizations11,969$50.5K
Dimensional Fund Advisors LP10,773$46.0K
Blackstone Group Inc.10,612$45.0K
Global Retirement Partners, LLC450$2.00K
Advisor Group Holdings, Inc.15$0

Not filed for Q4 2021 yet (1)

Institutions that held Alimera Sciences Inc at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ALIM in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Knott David M38,226$162.0K